Methods for reversible and tunable tissue magnification
This disclosure provides methods for producing size-adjustable tissue-hydrogel hybrids or cell-hydrogel hybrids for imaging cellular and subcellular details and system-scale (e.g., tissue or organism level) intercellular connectivity.
1. A method for preserving a tissue comprising:
perfusing or incubating a tissue with hydrogel subunits,
inducing polymerization of the hydrogel subunits under conditions comprising a concentration of hydrogel subunits that ranges from 25-80% weight/volume, and
denaturing and/or dissociating biomolecules in the tissue, thereby forming a size-adjustable tissue-hydrogel hybrid,
wherein the hydrogel subunits are acrylamide monomers.
2. The method of claim 1 , wherein the tissue is perfused or incubated under conditions that minimize inter- or intra-tissue binding.
3. The method of claim 1 , wherein the tissue is cultured cells.
4. The method of claim 1 , wherein the concentration of hydrogel subunits ranges from 30-70%, 30-80%, or 40-80%.
5. The method of claim 1 , wherein the tissue is perfused or incubated with hydrogel subunits and a fixative.
6. The method of claim 1 , wherein denaturing and/or dissociating biomolecules comprises contacting the tissue with a detergent, incubating at high temperature, mechanical dissociation, or sonication.
7. The method of claim 1 , wherein the tissue-hydrogel hybrid is reversibly and proportionally size-adjustable in three dimensions.
8. The method of claim 1 , further comprising reversibly size-adjusting the tissue-hydrogel hybrid.
9. The method of claim 8 , wherein reversibly size-adjusting the tissue-hydrogel hybrid comprises contacting the tissue-hydrogel hybrid with an aqueous solution or an aqueous saline solution.
10. The method of claim 1 , wherein the tissue has been perfused and fixed with fixative prior to being incubated with hydrogel subunits.
11. The method of claim 1 , wherein the concentration of hydrogel subunits is about 30%.
12. A method of producing a size-adjustable tissue-hydrogel hybrid comprising:
perfusing a tissue with a concentration of hydrogel subunits under conditions that minimize inter- or intra-tissue bonding, wherein said conditions comprise modulating the concentration of hydrogel subunits to be between 25-80% weight/volume,
inducing hybridization of the hydrogel subunits and tissue thereby forming a tissue-hydrogel hybrid, and
denaturing and/or dissociating biomolecules in the tissue-hydrogel hybrid, thereby forming a size-adjustable tissue-hydrogel hybrid,
wherein the hydrogel subunits are acrylamide monomers.